The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease.
Journal Information
Full Title: Xenobiotica
Abbreviation: Xenobiotica
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of interest S.A. Reisman and C.J. Meyer are employed by and have a financial interest in Reata Pharmaceuticals, Inc. M.A. Aminzadeh, N.D. Vaziri, J. Yuan and M. Khazaeli have received an unrestricted research grant from Reata Pharmaceuticals, Inc."
Funding Disclosure
Evidence found in paper:
"S.A. Reisman and C.J. Meyer are employed by and have a financial interest in Reata Pharmaceuticals, Inc. M.A. Aminzadeh, N.D. Vaziri, J. Yuan and M. Khazaeli have received an unrestricted research grant from Reata Pharmaceuticals, Inc."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025